Stanislaw Rajmund Burzynski (born January 23, 1943 in Lublin, Poland) is a biochemist and a physician. He is founder, president and chairman of Burzynski Research Institute Inc. , based in Houston and Stafford, Texas. Since December 1976, Burzynski has administered peptides and their metabolites, which he calls antineoplastons, as treatments with alleged anti-cancer activity.
In 1993, Burzynski was brought to court in Texas for treating patients with a treatment not approved by the Food and Drug Administration (FDA) and for selling antineoplastons in interstate commerce. In 1998 the Texas Attorney General, Dan Morales, placed limits on his advertising of antineoplastons and ordered him to cease and desist selling his products, without FDA supervised clinical trials. Burzynski had appealed the limitations on his advertising on the grounds of free speech, but the appeal court upheld the decision, stating that "Burzynski's commercial speech does not concern a lawful activity." Burzynski was also found guilty of fraud in 1994, as he claimed reimbursement from a health insurer for an illegally administered cancer treatment.Burzynski has a hearing with the Texas Medical Board in April 2012. The might well revoke his approbation.
- Texas State Board of Medical Examiners, Appellant v. Stanislaw R. Burzynski, M.D., Ph.D., Appellee Court judgement
<ref>tag; no text was provided for refs named
Cite error: Invalid
- Template:Cite web
- No. 93-2071 July 28, 1994. United States Court of Appeals, Fifth Circuit summary judgment.